John Bjornson
John Bjornson is Co-Founder and CEO at Singletto and serves as a mentor at RevTech Ventures and as an Investment Committee Member at The W Fund. He previously founded Bjornson Business Advisory and was President and Managing Director at Point B Capital, a VC-stage enterprise technology investment platform, and held executive roles at Singletto Inc. His expertise includes entrepreneurship, venture capital, management consulting, mentoring, and executive leadership.
Seattle Startup Singletto Launches FDA-Approved Virus-Killing Masks on Amazon Following $10M Funding and DARPA Support
Seattle startup Singletto, with $10 million in funding and support from DARPA, has launched FDA-approved virus-neutralizing face masks on Amazon using its Oxafence Active Protection technology that kills 99.9% of certain viruses. The masks are the only FDA-cleared products in the U.S. that inactivate tested viruses and may have applications in healthcare and national security.
Seattle Startup Singletto Gains FDA Approval for Virus-Killing Oxafence Surgical Masks
Seattle startup Singletto received FDA approval for its Oxafence technology, a methylene blue-treated surgical mask that kills 99.9% of certain viruses within five minutes. The masks are already in use in New Zealand and represent a significant advancement over traditional masks by actively inactivating pathogens.
Organizations
See all 5-
Singletto Executive Officer, Director 2020–present, Co-Founder and CEO 2020–present · current
-
RevTech Ventures Mentor 2017–present · current
-
The W Fund Investment Committee Member 2014–present · current
Education
-
Pacific Lutheran University BS, Computer Engineering, Engineering / Physics (EE minor) · 1985–1989
